These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

304 related items for PubMed ID: 22832941

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Tacalcitol and narrow-band phototherapy in patients with vitiligo.
    Leone G, Pacifico A, Iacovelli P, Paro Vidolin A, Picardo M.
    Clin Exp Dermatol; 2006 Mar; 31(2):200-5. PubMed ID: 16487090
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Treatment of vitiligo vulgaris with narrow-band UVB and oral Polypodium leucotomos extract: a randomized double-blind placebo-controlled study.
    Middelkamp-Hup MA, Bos JD, Rius-Diaz F, Gonzalez S, Westerhof W.
    J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):942-50. PubMed ID: 17659004
    [Abstract] [Full Text] [Related]

  • 6. Narrow-band UVB for the treatment of vitiligo: an emerging effective and well-tolerated therapy.
    Kanwar AJ, Dogra S, Parsad D, Kumar B.
    Int J Dermatol; 2005 Jan; 44(1):57-60. PubMed ID: 15663664
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of the effect of disease duration in generalized vitiligo on its clinical response to narrowband ultraviolet B phototherapy.
    Hallaji Z, Ghiasi M, Eisazadeh A, Damavandi MR.
    Photodermatol Photoimmunol Photomed; 2012 Jun; 28(3):115-9. PubMed ID: 22548391
    [Abstract] [Full Text] [Related]

  • 8. Dendritic cells: ultrastructural and immunophenotypical changes upon nb-UVB in vitiligo skin.
    Prignano F, Ricceri F, Bianchi B, Guasti D, Bonciolini V, Lotti T, Pimpinelli N.
    Arch Dermatol Res; 2011 May; 303(4):231-8. PubMed ID: 21174109
    [Abstract] [Full Text] [Related]

  • 9. Critical evaluation of the variants influencing the clinical response of vitiligo: study of 60 cases treated with ultraviolet B narrow-band phototherapy.
    Brazzelli V, Antoninetti M, Palazzini S, Barbagallo T, De Silvestri A, Borroni G.
    J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1369-74. PubMed ID: 17958843
    [Abstract] [Full Text] [Related]

  • 10. Leucine-rich glioma inactivated 3: a novel keratinocyte-derived melanogenic cytokine in vitiligo patients.
    Farag AGA, Hammam MA, Al-Sharaky DR, El-Boghdady GM.
    An Bras Dermatol; 2019 Nov; 94(4):434-441. PubMed ID: 31644616
    [Abstract] [Full Text] [Related]

  • 11. Targeted broadband ultraviolet b phototherapy produces similar responses to targeted narrowband ultraviolet B phototherapy for vitiligo: a randomized, double-blind study.
    Asawanonda P, Kijluakiat J, Korkij W, Sindhupak W.
    Acta Derm Venereol; 2008 Nov; 88(4):376-81. PubMed ID: 18709309
    [Abstract] [Full Text] [Related]

  • 12. Narrow-band UVB for the treatment of generalized vitiligo in children.
    Kanwar AJ, Dogra S.
    Clin Exp Dermatol; 2005 Jul; 30(4):332-6. PubMed ID: 15953060
    [Abstract] [Full Text] [Related]

  • 13. An open randomized study to compare narrow band UVB, topical pimecrolimus and topical tacrolimus in the treatment of vitiligo.
    Stinco G, Piccirillo F, Forcione M, Valent F, Patrone P.
    Eur J Dermatol; 2009 Jul; 19(6):588-93. PubMed ID: 19651562
    [Abstract] [Full Text] [Related]

  • 14. Antioxidants and narrow band-UVB in the treatment of vitiligo: a double-blind placebo controlled trial.
    Dell'Anna ML, Mastrofrancesco A, Sala R, Venturini M, Ottaviani M, Vidolin AP, Leone G, Calzavara PG, Westerhof W, Picardo M.
    Clin Exp Dermatol; 2007 Nov; 32(6):631-6. PubMed ID: 17953631
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Combination of narrow band UVB and topical calcipotriol for the treatment of vitiligo.
    Goktas EO, Aydin F, Senturk N, Canturk MT, Turanli AY.
    J Eur Acad Dermatol Venereol; 2006 May; 20(5):553-7. PubMed ID: 16684283
    [Abstract] [Full Text] [Related]

  • 18. Effect of narrow band ultraviolet B phototherapy as monotherapy or combination therapy for vitiligo: a meta-analysis.
    Li R, Qiao M, Wang X, Zhao X, Sun Q.
    Photodermatol Photoimmunol Photomed; 2017 Jan; 33(1):22-31. PubMed ID: 27696531
    [Abstract] [Full Text] [Related]

  • 19. Topical tacrolimus therapy for vitiligo: therapeutic responses and skin messenger RNA expression of proinflammatory cytokines.
    Grimes PE, Morris R, Avaniss-Aghajani E, Soriano T, Meraz M, Metzger A.
    J Am Acad Dermatol; 2004 Jul; 51(1):52-61. PubMed ID: 15243524
    [Abstract] [Full Text] [Related]

  • 20. Comparison between 308-nm monochromatic excimer light and narrowband UVB phototherapy (311-313 nm) in the treatment of vitiligo--a multicentre controlled study.
    Casacci M, Thomas P, Pacifico A, Bonnevalle A, Paro Vidolin A, Leone G.
    J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):956-63. PubMed ID: 17659006
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.